chr1-27954460-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_014474.4(SMPDL3B):c.624G>A(p.Ala208=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000602 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 0 hom. )
Consequence
SMPDL3B
NM_014474.4 synonymous
NM_014474.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.83
Genes affected
SMPDL3B (HGNC:21416): (sphingomyelin phosphodiesterase acid like 3B) Enables phosphoric diester hydrolase activity. Predicted to be involved in membrane lipid catabolic process; negative regulation of inflammatory response; and negative regulation of toll-like receptor signaling pathway. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-27954460-G-A is Benign according to our data. Variant chr1-27954460-G-A is described in ClinVar as [Benign]. Clinvar id is 728923.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.82 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMPDL3B | NM_014474.4 | c.624G>A | p.Ala208= | synonymous_variant | 5/8 | ENST00000373894.8 | |
SMPDL3B | NM_001009568.3 | c.624G>A | p.Ala208= | synonymous_variant | 5/7 | ||
SMPDL3B | NM_001304579.2 | c.6G>A | p.Ala2= | synonymous_variant | 5/8 | ||
SMPDL3B | XM_011541259.3 | c.714G>A | p.Ala238= | synonymous_variant | 6/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMPDL3B | ENST00000373894.8 | c.624G>A | p.Ala208= | synonymous_variant | 5/8 | 1 | NM_014474.4 | P1 | |
ENST00000448015.1 | n.286+1311C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00318 AC: 484AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
484
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000860 AC: 216AN: 251046Hom.: 2 AF XY: 0.000545 AC XY: 74AN XY: 135716
GnomAD3 exomes
AF:
AC:
216
AN:
251046
Hom.:
AF XY:
AC XY:
74
AN XY:
135716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000330 AC: 482AN: 1461776Hom.: 0 Cov.: 31 AF XY: 0.000272 AC XY: 198AN XY: 727174
GnomAD4 exome
AF:
AC:
482
AN:
1461776
Hom.:
Cov.:
31
AF XY:
AC XY:
198
AN XY:
727174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00321 AC: 489AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.00301 AC XY: 224AN XY: 74476
GnomAD4 genome
AF:
AC:
489
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
224
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 21, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at